Mechanism:Hormone inhibitor. Antioestrogenic activity by competing with oestrogen for binding sites in target organs.
Indications:lndicated in the treatment of Metastatic breast cancer. It is an alternative to oophorectomy or ovarian irradiation.Can be used in combination with cytotoxic drugs. Dosage: 20-40mg Doses greater than 20mg per da should be given in divided doses (morning and evening).
Tablets
39 EGP
Mechanism:Hormone inhibitor. Antioestrogenic activity by competing with oestrogen for binding sites in target organs.
Indications:lndicated in the treatment of Metastatic breast cancer. It is an alternative to oophorectomy or ovarian irradiation.Can be used in combination with cytotoxic drugs. Dosage: 20-40mg Doses greater than 20mg per da should be given in divided doses (morning and evening).
Note: All the provided information about this drug does not substitute for consulting a doctor.